{
  "paper_metadata": {
    "pmid": "33469799",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on four BRCA2 variants, including clinical significance, penetrance data, and functional studies."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.68-3T>G",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": 16,
        "demographics": "Not specified",
        "phenotype": "Not specified"
      },
      "penetrance_data": {
        "total_carriers_observed": 16,
        "affected_count": 0,
        "unaffected_count": 16,
        "uncertain_count": 0,
        "penetrance_percentage": 0.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "unaffected",
          "phenotype_details": "Not specified",
          "evidence_sentence": "The history weighting algorithm called this variant benign based on the relative severity of personal and family cancer history for c.68-3T>G carriers compared to negative controls."
        }
      ],
      "functional_data": {
        "summary": "Partial splice defect with some functional transcript produced.",
        "assays": [
          "RNA analysis",
          "RT-PCR",
          "Sanger sequencing"
        ]
      },
      "segregation_data": "Not specified",
      "population_frequency": "16/244,208 chromosomes; 0.01% allele frequency",
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Conflicting evidence regarding pathogenicity.",
      "key_quotes": [
        "c.68-3T>G results in a partial splice defect.",
        "The variant was classified as a variant of uncertain significance (VUS) in ClinVar."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.68-2A>G",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": 11,
        "demographics": "Not specified",
        "phenotype": "Not specified"
      },
      "penetrance_data": {
        "total_carriers_observed": 11,
        "affected_count": 0,
        "unaffected_count": 11,
        "uncertain_count": 0,
        "penetrance_percentage": 0.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "uncertain",
          "phenotype_details": "Not specified",
          "evidence_sentence": "BRCA2 c.68-2A>G did not meet the threshold to be classified as benign by the history weighting algorithm."
        }
      ],
      "functional_data": {
        "summary": "In-frame cryptic acceptor utilized, producing aberrant transcripts.",
        "assays": [
          "RNA analysis",
          "RT-PCR",
          "Sanger sequencing"
        ]
      },
      "segregation_data": "Not specified",
      "population_frequency": "1/243,416 chromosomes; 0% allele frequency",
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Trending benign but classified as VUS.",
      "key_quotes": [
        "The sequence change affects the invariant AG dinucleotide of the splice acceptor.",
        "Utilization of the cryptic splice site would produce a transcript with the in-frame deletion of two amino acids."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.425G>T",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Not specified",
        "phenotype": "Not specified"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 0,
        "unaffected_count": 10,
        "uncertain_count": 0,
        "penetrance_percentage": 0.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "uncertain",
          "phenotype_details": "Not specified",
          "evidence_sentence": "The history weighting algorithm analysis based on 10 observations."
        }
      ],
      "functional_data": {
        "summary": "Expected to cause skipping of exon 4, leading to pathogenic effects.",
        "assays": [
          "RNA analysis",
          "RT-PCR",
          "Sanger sequencing"
        ]
      },
      "segregation_data": "Not specified",
      "population_frequency": "Not present in large population databases",
      "evidence_level": "Strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Classified as likely pathogenic based on multiple lines of evidence.",
      "key_quotes": [
        "c.425G>T was classified as likely pathogenic in ClinVar by six submitting laboratories.",
        "Published RNA analysis showing skipping of exon 4 with predicted protein truncation."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.8331+2T>C",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": 0,
        "demographics": "Not specified",
        "phenotype": "Not specified"
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Partial splice defect with some functional transcript produced.",
        "assays": [
          "RNA analysis",
          "RT-PCR",
          "Sanger sequencing"
        ]
      },
      "segregation_data": "Not specified",
      "population_frequency": "Not present in large population databases",
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Classified as VUS due to conflicting evidence.",
      "key_quotes": [
        "BRCA2 c.8331+2T>C may utilize a functional GC donor in place of the wild-type GT donor."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Summary of evidence for variant classification.",
      "variants_extracted": 4
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 4,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data extracted from the main text and tables."
  }
}